• DIA 2023 Topic: The Industry-Wide Definition for RBQM

    Clinical Research News | At an RBQM expert dinner hosted by CluePoints and the Tufts Center for the Study of Drug Development’s (CSDD), Ken Getz shared the results of a global industry-wide survey on RBQM adoption and attitudes. The survey was conducted by Ken and his team at the Tufts CSDD in collaboration with CluePoints and Price Waterhouse Cooper.

    Oct 6, 2023

  • NCI To Conduct Massive Study To Evaluate Multi-Cancer Detection Assays

    Clinical Research News | The importance of data has become apparent to everybody in recent years. We can now interrogate massive datasets to add value to clinical trials and utilize technology more efficiently to speed up time to market.

    Oct 3, 2023

  • Medidata Launches Diversity Program, HHS Extends Partnership to Develop Monoclonal Antibodies, Flatiron Renews FDA Collab

    Clinical Research News | Flatiron Health renewed its collaboration with the Oncology Center of Excellence (OCE) of the United States Food and Drug Administration (FDA) to jointly develop and implement specific research projects; Medidata launched a program to improve diversity, equity, and inclusion in clinical trials; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.

    Sep 28, 2023

  • Follow the Money: NCI Awards Grant For Prostate Cancer Treatment Study, Recruiting Participants For Immunotherapy Drug Trials

    Clinical Research News | The Icahn School of Medicine at Mount Sinai nets a grant to identify the best prostate cancer treatment for people with HIV; EverImmune will conduct a phase I/II clinical trial for its drug candidate Oncobax AK in patients undergoing immunotherapy; NIH establishes the Multi-Omics for Health and Disease Consortium to advance the generation and analysis of “multi-omic” data for human health research; more.

    Sep 27, 2023